May 28, 2026 09:10AM
May 28, 2026 09:10AM
May 22, 2026 07:00AM
May 19, 2026 07:00AM
May 19, 2026 07:00AM
May 13, 2026 04:01PM
May 13, 2026 04:01PM Medicenna Announces the Launch of a Marketed Public Offering of Securities
May 12, 2026 07:00AM
Apr 30, 2026 07:30AM
Apr 21, 2026 07:30AM
Apr 14, 2026 07:30AM
Feb 13, 2026 08:09AM
Dec 9, 2025 05:04PM
Nov 13, 2025 07:00AM Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
Oct 23, 2025 05:12PM
Apr 22, 2025 07:00AM
Apr 1, 2025 07:00AM
Mar 26, 2025 07:00AM
Feb 25, 2025 07:05AM
Feb 25, 2025 07:00AM
Feb 13, 2025 10:28AM Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
Feb 5, 2025 07:00AM
Dec 13, 2024 08:30AM
Dec 5, 2024 07:35AM
Nov 27, 2024 07:02AM
Nov 27, 2024 07:00AM
Nov 25, 2024 07:30AM
Nov 15, 2024 07:30AM Medicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update
Nov 13, 2024 07:00AM
Nov 11, 2024 07:00AM
Nov 8, 2024 10:00AM
Oct 4, 2024 09:07AM
Sep 26, 2024 05:00PM
Sep 9, 2024 07:32AM
Sep 5, 2024 07:00AM Medicenna to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
Aug 27, 2024 07:00AM
Aug 15, 2024 07:31AM
Aug 15, 2024 07:30AM
Aug 1, 2024 07:00AM
Jun 27, 2024 08:18AM
Jun 26, 2024 07:47AM
Jun 3, 2024 08:00AM Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
May 31, 2024 09:29AM
May 22, 2024 07:00AM
May 13, 2024 07:00AM
Apr 24, 2024 10:05AM
Apr 10, 2024 06:32AM
Apr 10, 2024 06:30AM
Apr 9, 2024 04:30PM Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the America
Apr 9, 2024 12:01PM

322,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All